Patent · US Active

RNA transcription vector and uses thereof

US10864284B2 · kind B2 · utility

0Cited by

5References

8Claims

0Family size

Assignee

VRIJE UNIVERSITEIT BRUSSEL · BE

Inventors

Carlo Heirman · Dendermonde, BE
Kristiaan Thielemans · Ekeren, BE

Key dates

Filing date	Aug 21, 2018
Grant date	Dec 15, 2020
Priority date	—
Expiry date	Aug 21, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2840/105
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention in general relates to an improved RNA transcription vector, which is very suitable for the production of mRNA for in vivo therapeutic purposes. The improvements in the vector in particular reside in the presence of a transcription enhancer and a nuclear retention element.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.